Haeri Mazanderani A, Sherman G G, Moyo F, Goga A E, Feucht U
Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg; and Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, South Africa.
S Afr Med J. 2018 Aug 30;108(9):729-733. doi: 10.7196/SAMJ.2018.v108i9.13093.
Currently there is no unique patient identification system in the South African public health sector. Therefore, routine laboratory data cannot effectively be de-duplicated, thereby hampering surveillance of laboratory-diagnosed diseases such as mother-to-child transmission of HIV.
To determine the uptake of Road to Health booklet (RTHB) identifiers at HIV polymerase chain reaction (PCR) birth test and describe their performance in linking follow-up test results in the early infant diagnosis programme.
Between May 2016 and May 2017, Tshwane District Clinical Services implemented a unique patient identifier pilot project in which a sticker-page of unique, readable, barcoded patient identifiers was incorporated in the patient-retained immunisation record (the RTHB) before distribution. Uptake of RTHB identifiers at birth was calculated as the proportion of HIV PCR tests in infants aged <6 days registered with an RTHB identifier over the total number of registered HIV PCR tests. Descriptive analysis of demographic details was performed among infants with two registered HIV PCR tests linked by the RTHB identifier, and performance of the National Health Laboratory Service Corporate Data Warehouse (NHLS CDW)-linking algorithm in matching RTHB-linked results was calculated using a 2 × 2 table.
A total of 5 309 HIV PCR birth tests registered with an RTHB identifier were extracted from the NHLS CDW over the 13-month period of the pilot project. The number of registered RTHB identifiers increased from 24 (2% of birth PCR tests) in May 2016, peaking at 728 (56% of birth PCR tests) in May 2017. Among infants with a registered RTHB identifier at birth, 635 (12%) had a subsequent linked HIV PCR test, as indicated by the same RTHB number registered for a later specimen. Demographic details at the time of birth and subsequent PCR test were compared, demonstrating that <4% of infants had exact matches for name, surname, date of birth and sex; 74% of birth tests had variations such as 'born to' or 'baby of ' in place of a first name; surnames matched exactly in 61% of cases; 18% (n=116) of infants had both tests performed at the same facility, of which only 27% (n=31) had the same patient folder number on both test results.
Leveraging RTHBs as unique patient identifiers, even if used temporarily until linkage to other future national unique identifiers, promises to be an effective scalable approach to laboratory-based surveillance, facilitating healthcare provider access to all test results from birth.
目前南非公共卫生部门没有统一的患者识别系统。因此,常规实验室数据无法有效去重,从而阻碍了对实验室诊断疾病(如艾滋病毒母婴传播)的监测。
确定在艾滋病毒聚合酶链反应(PCR)出生检测中《健康之路手册》(RTHB)标识符的使用情况,并描述其在早期婴儿诊断计划中关联后续检测结果的表现。
2016年5月至2017年5月期间,茨瓦内区临床服务部门实施了一个统一患者标识符试点项目,在分发前将一页带有唯一、可读、条形码患者标识符的贴纸纳入患者留存的免疫记录(即RTHB)。出生时RTHB标识符的使用率计算为年龄小于6天且登记有RTHB标识符的婴儿的艾滋病毒PCR检测数占登记的艾滋病毒PCR检测总数的比例。对通过RTHB标识符关联的两次登记的艾滋病毒PCR检测的婴儿进行人口统计学详细信息的描述性分析,并使用2×2表格计算国家卫生实验室服务公司数据仓库(NHLS CDW)关联算法在匹配RTHB关联结果方面的表现。
在试点项目的13个月期间,从NHLS CDW中提取了总共5309次登记有RTHB标识符的艾滋病毒PCR出生检测。登记的RTHB标识符数量从2016年5月的24个(占出生PCR检测的2%)增加到2017年5月的728个(占出生PCR检测的56%)。在出生时登记有RTHB标识符的婴儿中,635个(12%)随后有一次关联的艾滋病毒PCR检测,这由为后续样本登记的相同RTHB编号表明。比较了出生时和后续PCR检测时的人口统计学详细信息,结果显示不到4%的婴儿在姓名、姓氏、出生日期和性别方面完全匹配;74%的出生检测存在诸如“由……所生”或“……的婴儿”等代替名字的变体;61%的病例中姓氏完全匹配;18%(n = 116)的婴儿两次检测在同一机构进行,其中只有27%(n = 31)的两次检测结果上有相同的患者文件夹编号。
利用RTHB作为统一的患者标识符,即使在与未来其他国家统一标识符建立关联之前临时使用,有望成为一种有效的可扩展的基于实验室监测的方法,便于医疗服务提供者获取从出生起的所有检测结果。